{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:25:51Z","timestamp":1746339951216},"reference-count":16,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.56.7944","type":"journal-article","created":{"date-parts":[[2017,4,30]],"date-time":"2017-04-30T18:11:36Z","timestamp":1493575896000},"page":"1079-1083","source":"Crossref","is-referenced-by-count":3,"title":["Fatal Unusual Miliary Tuberculosis in which a Patient Developed Acute Respiratory Distress Syndrome Induced by Infliximab: An Autopsy Case Report"],"prefix":"10.2169","volume":"56","author":[{"given":"Shion","family":"Miyoshi","sequence":"first","affiliation":[{"name":"Department of Pulmonary Medicine, National Center for Global Health and Medicine, Japan"},{"name":"Department of Respiratory Medicine, Toho University Omori Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Takasaki","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, National Center for Global Health and Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohtaro","family":"Mine","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Center for Global Health and Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Kono","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, National Center for Global Health and Medicine, Japan"},{"name":"Department of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Igari","sequence":"additional","affiliation":[{"name":"Department of Pathology, National Center for Global Health and Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Takeda","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, National Center for Global Health and Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Hojo","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, National Center for Global Health and Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhito","family":"Sugiyama","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, National Center for Global Health and Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345: 1098-1104, 2001.","DOI":"10.1056\/NEJMoa011110"},{"key":"2","first-page":"2526","volume":"307","author":"VM Ranieri","year":"2012","unstructured":"2. Ranieri VM, Rubenfeld GD, Thompson BT, et al; ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin Definition. JAMA 307: 2526-2533, 2012.","journal-title":"JAMA The Journal of the American Medical Association","ISSN":"http:\/\/id.crossref.org\/issn\/0098-7484","issn-type":"print"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Hong Kong Chest Service\/Tuberculosis Research Centre, Madras\/British Medical Research Council. Am Rev Respir Dis 145: 36-41, 1992.","DOI":"10.1164\/ajrccm\/145.1.36"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Smieja MJ, Marchetti CA, Cook DJ, Smaill FM. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane database syst rev. Cd001363. 2000.","DOI":"10.1002\/14651858.CD001363"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. British Thoracic Society Standards of Care Committee. BTS recommendations for assessing risk and for managing <i>Mycobacterium tuberculosis<\/i> infection and disease in patients due to start anti-TNF-alpha treatment. Thorax 60: 800-805, 2005.","DOI":"10.1136\/thx.2005.046797"},{"key":"6","unstructured":"6. Mori T, Harada N, Higuchi K, Sekiya Y, Uchimura K, Shimao T. Waning of the specific interferon-gamma response after years of tuberculosis infection. Int J Tuberc Lung Dis 11: 1021-1025, 2007."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. de Noronha AL, Bafica A, Nogueira L, Barral A, Barral-Netto M. Lung granulomas from <i>Mycobacterium tuberculosis<\/i>\/HIV-1 co-infected patients display decreased <i>in situ<\/i> TNF production. Pathol Res Pract 204: 155-161, 2008.","DOI":"10.1016\/j.prp.2007.10.008"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Munt PW. Miliary tuberculosis in the chemotherapy era: with a clinical review in 69 American adults. Medicine (Baltimore) 51: 139-155, 1972.","DOI":"10.1097\/00005792-197203000-00004"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Maartens G, Willcox PA, Benatar SR. Miliary tuberculosis: rapid diagnosis, hematologic abnormalities, and outcome in 109 treated adults. Am J Med 89: 291-296, 1990.","DOI":"10.1016\/0002-9343(90)90340-J"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Takahashi S, Setoguchi Y, Nukiwa T, Kira S. Soluble interleukin-2 receptor in sera of patients with pulmonary tuberculosis. Chest 99: 310-314, 1991.","DOI":"10.1378\/chest.99.2.310"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Brown AE, Rieder KT, Webster HK. Prolonged elevations of soluble interleukin-2 receptors in tuberculosis. Am Rev Respir Dis 139: 1036-1038, 1989.","DOI":"10.1164\/ajrccm\/139.4.1036"},{"key":"12","unstructured":"12. Sharma SK, Mohan A, Sharma A. Challenges in the diagnosis &amp; treatment of miliary tuberculosis. Indian J Med Res 135: 703-730, 2012."},{"key":"13","unstructured":"13. Al-Jahdali H, Al-Zahrani K, Amene P, et al. Clinical aspects of miliary tuberculosis in Saudi adults. Int J Tuberc Lung Dis 4: 252-255, 2000."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Garcia Vidal C, Rodriguez Fernandez S, Martinez Lacasa J, et al. Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis. Clin Infect Dis 40: 756-759, 2005.","DOI":"10.1086\/427941"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Wallis RS, van Vuuren C, Potgieter S. Adalimumab treatment of life-threatening tuberculosis. Clin Infect Dis 48: 1429-1432, 2009.","DOI":"10.1086\/598504"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Arend SM, Leyten EM, Franken WP, Huisman EM, van Dissel JT. A patient with de novo tuberculosis during anti-tumor necrosis factor-alpha therapy illustrating diagnostic pitfalls and paradoxical response to treatment. Clin Infect Dis 45: 1470-1475, 2007.","DOI":"10.1086\/522993"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/9\/56_56.7944\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T11:39:13Z","timestamp":1569152353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/9\/56_56.7944\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.56.7944","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}